Key Record Dates
ClinicalTrials.gov Identifier: | NCT05014828 |
---|---|
Brief Title: | To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Patients With Selected Solid Tumors |
First Submitted : | July 28, 2021 |
First Submitted that Met QC Criteria : | August 16, 2021 |
First Posted : | August 20, 2021 |
Last Update Submitted that Met QC Criteria : | May 22, 2023 |
Last Update Posted : | May 23, 2023 |